九十岁及以上高龄患者择期全髋关节置换术的结局
基于2008-2017年美国外科医师学会国家质量改进计划的回顾性队列,将858例90岁及以上行初次全髋关节置换术的患者与858例65-89岁患者按倾向评分匹配,比较30天结局。结论认为全髋关节置换术在90岁以上仍是安全可行的治疗方式,临床决策应主要依据患者合并症而非年龄。
要点
- 90岁及以上患者行全髋关节置换术后30天严重并发症发生率与65-89岁患者无显著差异。
- 30天再手术、再入院和死亡率在两组间无显著差异,临床决策应主要依据合并症而非年龄。
核心结论
- 全髋关节置换术在90岁以上患者中仍是安全可行的治疗方式,患者合并症谱而非年龄应主导共享临床决策。
研究设计与样本
- 回顾性队列研究,使用2008-2017年美国外科医师学会国家质量改进计划数据库,通过倾向评分将858例90岁及以上行初次全髋关节置换术的患者与858例65-89岁患者匹配,控制人口学因素和合并症。
临床怎么用
- 对于90岁及以上需行全髋关节置换术的患者,应综合评估合并症而非仅凭年龄决定手术。
- 术后需关注尿路感染预防、延长住院和出院安排,可能需转入非家庭机构康复。
局限性
- 本研究为回顾性队列研究,仅评估30天短期结局,缺乏长期功能结果和患者报告结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonagenarians and centenarians are among the fastest growing demographics in the United States. Although consequent demand for joint replacement is projected to rise precipitously, outcomes of total hip arthroplasty (THA) have seldom been studied in this population. METHODS: A retrospective cohort of patients undergoing primary THA was established using the 2008-2017 American College of Surgeons National Quality Improvement Program. Propensity scores were used to match 858 patients aged 90 or older to 858 patients aged 65-89, controlling for demographic factors and comorbidities. Thirty-day outcomes were compared between matched age cohorts using multiple regression modeling. RESULTS: Statistically equivalent 30-day rates of surgical infection (P = .73), pneumonia (P = .39), deep venous thrombosis/thrombophlebitis (P = .55), pulmonary embolism (P = .69), stroke (P = .73), myocardial infarction (P = .44), cardiac arrest (P = .69), and sepsis (P = .77) were observed between matched age cohorts, although nonagenarians and centenarians were significantly more likely to experience urinary tract infection (2.8% vs 0.9%, P = .004). In addition, matched patients aged 90 or older were more likely to have longer hospital stays (3.52 vs 2.81 days, P < .001) and be discharged to a nonhome facility (75.4% vs 34.6%, P < .001) but were at no higher than 30-day risk of reoperation (P = .45), readmission (P = .23), or mortality (P = .59). CONCLUSION: Overall, THA remains a safe and viable treatment modality beyond the ninth decade of life. Patient comorbidity profiles, rather than age, should principally guide shared clinical decision making.
引用
- Sherman AE, Plantz MA, Hardt KD, et al. Outcomes of Elective Total Hip Arthroplasty in Nonagenarians and Centenarians. J Arthroplasty. 2020. PMID: 32312644. doi:10.1016/j.arth.2020.03.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。